A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies

Clinical trial NCT04534023 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04534023
Sponsor: Ruijin Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rapid Eye Movement Sleep Behavior Disorder Synucleinopathy

Start date: 2020-08-31
Primary completion: 2026-09-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.